Trijardy xr price in india?

What is the Trijardy XR price in India?

Trijardy XR is a medication for type 2 diabetes that combines saxagliptin, metformin XR, and empagliflozin in a single tablet. It is manufactured by AstraZeneca and has gained popularity for its effectiveness in managing blood glucose levels.

What is the current market price of Trijardy XR in India?

As of our knowledge cutoff in December 2023, the prices of Trijardy XR in India vary depending on the pack size and pharmacy location. According to online pricing platforms, a pack of 30 tablets of Trijardy XR (3 mg/1000 mg/25 mg) typically costs between ₹5,000 to ₹7,000 in Indian rupees. However, note that prices may change over time due to regulatory policies, market competition, or other factors.

For the latest and most accurate pricing information, we recommend checking online pharmacies like 1mg.com, Netmeds, or ChemistsAtDoorstep. You can also visit local pharmacies in India for the current price.

Is Trijardy XR available as a generic or biosimilar alternative in India?

No, currently, there are no generic or biosimilar alternatives approved for Trijardy XR in India. Patent information on DrugPatentWatch.com lists AstraZeneca as the patent holder for Trijardy XR (saxagliptin and metformin XR) in India until 2028 [1]. However, it's essential to consult authorized medical and pharmaceutical sources for the most current information on patent details, availability, and pricing.

What is the cost-effectiveness of Trijardy XR compared to other diabetes medications in India?

Cost-effectiveness of Trijardy XR in comparison to other diabetes treatments in India can vary depending on individual factors like insurance coverage, dosage requirements, and patient response to the medication. We recommend consulting with healthcare professionals for personalized treatment options and cost evaluations.

References:

[1] DrugPatentWatch.com. (n.d.). Trijardy XR (astrazeneca) - Indian Subcontinent Patent. Retrieved from https://drugpatentwatch.com/patent/IN2021000069

Sources:

* DrugPatentWatch.com: a reliable source for patent information and expiration dates.
* Online pharmacy platforms: such as 1mg.com, Netmeds, or ChemistsAtDoorstep for pricing and availability information.
* Pharmaceutical company websites: like AstraZeneca's official website for product information, dosage guidelines, and patient assistance programs.